Top

Published in:

01-01-2004 | Technology Review

Expression Systems for the Production of Recombinant Pharmaceuticals

Author: Dr Régis Sodoyer

Published in: BioDrugs | Issue 1/2004

Abstract

The new generation of biological products are largely the result of genetic engineering. The qualitative and quantitative demand for recombinant proteins is steadily increasing. Molecular biologists are constantly challenged by the need to improve and optimise the existing expression systems, and also develop novel approaches to face the demands of producing the complex proteins of tomorrow. This continuous evolution is paralleled by growing concerns about the safety of these novel pharmaceuticals, with health authorities setting high standards for certification. One of the strategies used by researchers in this field involves sourcing new genetic elements for incorporation into expression systems by systematically analysing the rich natural diversity of microorganisms and plant-based expression systems. There are, in addition, numerous tools for modifying microorganisms and for re-engineering existing biological pathways or processes to meet the needs of the pharmaceutical industry. The aim of this review is to present the conventional and alternative expression systems, focusing on prokaryotic expression systems and briefly exploring other complementary recombinant protein production systems and their unique features.

The use of tradenames is for product identification purposes only and does not imply endorsement.

Studier FW, Moffatt BA. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 1986 May 5; 189(1): 113–30PubMedCrossRef

Matthey B, Engert A, Klimka A, et al. A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteins. Gene 1999 Mar 18; 229(1-2): 145–53PubMedCrossRef

Tabor S, Richardson CC. A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes. Proc Natl Acad Sci U S A 1985 Feb; 82(4): 1074–8PubMedCrossRef

Newman JR, Fuqua C. Broad-host-range expression vectors that carry the Larabinose-inducible Escherichia coli araBAD promoter and the araC regulator. Gene 1999 Feb 18; 227(2): 197–203PubMedCrossRef

Bass SH, Yansura DG. Application of the E. coli trp promoter. Mol Biotechnol 2000 Nov; 16(3): 253–60PubMedCrossRef

Chevalet L, Robert A, Gueneau F, et al. Recombinant protein production driven by the tryptophan promoter is tightly controlled in ICONE 200, a new genetically engineered E. coli mutant. Biotechnol Bioeng 2000 Aug 20; 69(4): 351–8PubMedCrossRef

Carbonell X, Corchero JL, Cubarsi R, et al. Control of Escherichia coli growth rate through cell density. Microbiol Res 2002; 157(4): 257–65PubMedCrossRef

Oh TJ, Jung IL, Kim IG. The Escherichia coli SOS gene sbmC is regulated by HNS and RpoS during the SOS induction and stationary growth phase. Biochem Biophys Res Commun 2001 Nov 9; 288(4): 1052–8PubMedCrossRef

Rowe DC, Summers DK. The quiescent-cell expression system for protein synthesis in Escherichia coli. Appl Environ Microbiol 1999 Jun; 65(6): 2710–5PubMed

10.

Sektas M, Hasan N, Szybalski W. Expression plasmid with a very tight two-step control: Int/att-mediated gene inversion with respect to the stationary promoter. Gene 2001 Apr 18; 267(2): 213–20PubMedCrossRef

11.

Kleber-Janke T, Becker WM. Use of modified BL21 (DE3) Escherichia coli cells for high-level expression of recombinant peanut allergens affected by poor codon usage. Protein Expr Purif 2000 Aug; 19(3): 419–24PubMedCrossRef

12.

Lakey DL, Voladri RK, Edwards KM, et al. Enhanced production of recombinant Mycobacterium tuberculosis antigens in Escherichia coli by replacement of low-usage codons. Infect Immun 2000 Jan; 68(1): 233–8PubMedCrossRef

13.

Baca AM, Hol WG. Overcoming codon bias: a method for high-level over expression of Plasmodium and other AT-rich parasite genes in Escherichia coli. Int J Parasitol 2000 Feb; 30(2): 113–8PubMedCrossRef

14.

Lammertyn E, Van Mellaert L, Bijnens AP, et al. Codon adjustment to maximise heterologous gene expression in Streptomyces lividans can lead to decreased mRNA stability and protein yield. Mol Gen Genet 1996 Feb 5; 250(2): 223–9PubMed

15.

Kurland CG. Codon bias and gene expression. FEBS Lett 1991 Jul 22; 285(2): 165–9PubMedCrossRef

16.

Buckingham RH. Codon context and protein synthesis: enhancements of the genetic code. Biochimie 1994; 76(5): 351–4PubMedCrossRef

17.

Karlin S, Mrazek J, Campbell AM. Codon usages in different gene classes of the Escherichia coli genome. Mol Microbiol 1998 Sep; 29(6): 1341–55PubMedCrossRef

18.

Humphreys DP, Sehdev M, Chapman AP, et al. High-level periplasmic expression in Escherichia coli using a eukaryotic signal peptide: importance of codon usage at the 5′end of the coding sequence. Protein Expr Purif 2000 Nov; 20(2): 252–64PubMedCrossRef

19.

Moszer I, Rocha EP, Danchin A. Codon usage and lateral gene transfer in Bacillus subtilis. Curr Opin Microbiol 1999 Oct; 2(5): 524–8PubMedCrossRef

20.

Karlin S, Barnett MJ, Campbell AM, et al. Predicting gene expression levels from codon biases in alpha-proteobacterial genomes. Proc Natl Acad Sci U S A 2003 Jun 10; 100(12): 7313–8PubMedCrossRef

21.

de Smit MH, van Duin J. Translational standby sites: how ribosomes may deal with the rapid folding kinetics of mRNA. J Mol Biol 2003 Aug 22; 331(4): 737–43PubMedCrossRef

22.

Schwarz E, Lilie H, Rudolph R. The effect of molecular chaperones on in vivo and in vitro folding processes. Biol Chem 1996 Jul-Aug; 377(7-8): 411–6PubMed

23.

Thomas JG, Ayling A, Baneyx F. Molecular chaperones, folding catalysts, and the recovery of active recombinant proteins from E. coli: to fold or to refold. Appl Biochem Biotechnol 1997 Jun; 66(3): 197–238PubMedCrossRef

24.

Stevens JM, Rao Saroja N, Jaouen M, et al. Chaperone-assisted expression, purification, and characterization of recombinant nitrile hydratase NI1 from Comamonas testosteroni. Protein Expr Purif 2003 May; 29(1): 70–6PubMedCrossRef

25.

Laage R, Langosch D. Strategies for prokaryotic expression of eukaryotic membrane proteins. Traffic 2001 Feb; 2(2): 99–104PubMedCrossRef

26.

Chen BP, Hai T. Expression vectors for affinity purification and radiolabeling of proteins using Escherichia coli as host. Gene 1994 Feb 11; 139(1): 73–5PubMedCrossRef

27.

Einhauer A, Jungbauer A. The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins. J Biochem Biophys Methods 2001 Oct 30; 49(1-3): 455–65PubMedCrossRef

28.

Humphreys DP, King LM, West SM, et al. Improved efficiency of site-specific copper (II) ion-catalysed protein cleavage effected by mutagenesis of cleavage site. Protein Eng 2000 Mar; 13(3): 201–6PubMedCrossRef

29.

Wang T, Evdokimov E, Yiadom K, et al. Biotin-ubiquitin tagging of mammalian proteins in Escherichia coli. Protein Expr Purif2003 Jul; 30(1): 140–9PubMedCrossRef

30.

Chong S, Mersha FB, Comb DG, et al. Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein splicing element. Gene 1997 Jun 19; 192(2): 271–81PubMedCrossRef

31.

Kirkpatrick RB, McDevitt PJ, Matico RE, et al. A bicistronic expression system for bacterial production of authentic human interleukin-18. Protein Expr Purif 2003 Feb; 27(2): 279–92PubMedCrossRef

32.

Tarragona-Fiol A, Taylorson CJ, Ward JM, et al. Production of mature bovine pancreatic ribonuclease in Escherichia coli. Gene 1992 Sep 10; 118(2): 239–45PubMedCrossRef

33.

Ishida M, Oshima T, Yutani K. Overexpression in Escherichia coli of the AT-rich trpA and trpB genes from the hyperthermophilic archaeon Pyrococcus furiosus. FEMS Microbiol Lett 2002 Nov 5; 216(2): 179–83PubMedCrossRef

34.

Chatwin HM, Summers DK. Monomer-dimer control of the ColE1 P(cer) promoter. Microbiology 2001 Nov; 147 (Pt 11): 3071–81PubMed

35.

Wilms B, Hauck A, Reuss M, et al. High-cell-density fermentation for production of L-N-carbamoylase using an expression system based on the Escherichia coli rhaBAD promoter. Biotechnol Bioeng 2001 Apr 20; 73(2): 95–103PubMedCrossRef

36.

Gerdes K, Bech FW, Jorgensen ST, et al. Mechanism of postsegregational killing by the hok gene product of the parB system of plasmid R1 and its homology with the relF gene product of the E. coli relB operon. EMBO J 1986 Aug; 5(8): 2023–9PubMed

37.

Chambers SP, Prior SE, Barstow DA, et al. The pMTL niccloning vectors: I. Improved pUC polylinker regions to facilitate the use of sonicated DNA for nucleotide sequencing. Gene 1988 Aug 15; 68(1): 139–49PubMedCrossRef

38.

Degryse E. Stability of a host-vector system based on complementation of an essential gene in Escherichia coli. J Biotechnol 1991 Apr; 18(1-2): 29–39PubMedCrossRef

39.

Cranenburgh RM, Hanak JA, Williams SG, et al. Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration [letter]. Nucleic Acids Res 2001 Mar 1; 29(5): E26PubMedCrossRef

40.

Soubrier F,Cameron B, Manse B, et al. pCOR: a new design of plasmid vectors for nonviral gene therapy. Gene Ther 1999 Aug; 6(8): 1482–8PubMedCrossRef

41.

Link AJ, Phillips D, Church GM. Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli: application to open reading frame characterization. J Bacteriol 1997 Oct; 179(20): 6228–37PubMed

42.

Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000 Jun 6; 97(12): 6640–5PubMedCrossRef

43.

Tokuyasu K, Kaneko S, Hayashi K, et al. Production of a recombinant chitin deacetylase in the culture medium of Escherichia coli cells. FEBS Lett 1999 Sep 10; 458(1): 23–6PubMedCrossRef

44.

Forsberg G, Forsgren M, Jaki M, et al. Identification of framework residues in a secreted recombinant antibody fragment that control production level and localization in Escherichia coli. J Biol Chem 1997 May 9; 272(19): 12430–6PubMedCrossRef

45.

Sauvonnet N, Pugsley AP. Identification of two regions of Klebsiella oxytoca pullulanase that together are capable of promoting beta-lactamase secretion by the general secretory pathway. Mol Microbiol 1996 Oct; 22(1): 1–7PubMedCrossRef

46.

Loo T, Patchett ML, Norris GE, et al. Using secretion to solve a solubility problem: high-yield expression in Escherichia coli and purification of the bacterial glycoamidase PNGase F. Protein Expr Purif 2002 Feb; 24(1): 90–8PubMedCrossRef

47.

Pines O, Inouye M. Expression and secretion of proteins in E. coli. Mol Biotechnol 1999 Aug; 12(1): 25–34PubMedCrossRef

48.

Lei SP, Lin HC, Wang SS, et al. Characterization of the Erwinia carotovora pelB gene and its product pectate lyase. J Bacteriol 1987 Sep; 169(9): 4379–83PubMed

49.

Simmons LC, Yansura DG. Translational level is a critical factor for the secretion of heterologous proteins in Escherichia coli. Nat Biotechnol 1996 May; 14(5): 629–34PubMedCrossRef

50.

Simmons LC, Reilly D, Klimowski L, et al. Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. J Immunol Methods 2002 May 1; 263(1-2): 133–47PubMedCrossRef

51.

Yu P, San KY. Protein release in recombinant Escherichia coli using bacteriocin release protein. Biotechnol Prog 1992 Jan-Feb; 8(1): 25–9PubMedCrossRef

52.

Fu Z, Hamid SB, Razak CN, et al. Secretory expression in Escherichia coli and single-step purification of a heat-stable alkaline protease. Protein Expr Purif 2003 Mar; 28(1): 63–8PubMedCrossRef

53.

Robbens J, Raeymaekers A, Steidler L, et al. Production of soluble and active recombinant murine interleukin-2 in Escherichia coli: high level expression, Kil-induced release, and purification. Protein Expr Purif 1995 Aug; 6(4): 481–6PubMedCrossRef

54.

Wacker M, Linton D, Hitchen PG, et al. N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science 2002 Nov 29; 298(5599): 1790–3

55.

Ravn P, Arnau J, Madsen SM, et al. Optimization of signal peptide SP310 for heterologous protein production in Lactococcus lactis. Microbiology 2003 Aug; 149 (Pt 8): 2193–201PubMedCrossRef

56.

Bredmose L, Madsen SM, Vrang A. Commercial production of heterologous proteins in Lactococcus lactis [poster]. 2nd International Conference on Recombinant Protein Production with Prokaryotic and Eukaryotic Cells; 2002 Nov 14-16; Cernobio

57.

Mercenier A, Muller-Alouf H, Grangette C. Lactic acid bacteria as live vaccines. Curr Issues Mol Biol 2000 Jan; 2(1): 17–25PubMed

58.

Kruger C, Hu Y, Pan Q, et al. In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat Biotechnol 2002 Jul; 20(7): 702–6PubMedCrossRef

59.

Steidler L, Neirynck S, Huyghebaert N, et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 2003 Jul; 21(7): 75–9CrossRef

60.

Beninati C, Oggioni MR, Boccanera M, et al. Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat Biotechnol 2000 Oct; 18(10): 1060–4PubMedCrossRef

61.

Pogliano JA, Beckwith J. SecD and SecF facilitate protein export in Escherichia coli. EMBO J 1994 Feb 1; 13(3): 554–61PubMed

62.

DeLisa MP, Samuelson P, Palmer T, et al. Genetic analysis of the twin arginine translocator secretion pathway in bacteria. J Biol Chem 2002 Aug 16; 277(33): 29825–31PubMedCrossRef

63.

Bingle WH, Smit J. High-level expression vectors for Caulobacter crescentus incorporating the transcription/translation initiation regions of the paracrystalline surface-layer-protein gene. Plasmid 1990 Sep; 24(2): 143–8PubMedCrossRef

64.

Simon B, Nomellini J, Chiou P, et al. Recombinant vaccines against infectious hematopoietic necrosis virus: production by the Caulobacter crescentus S-layer protein secretion system and evaluation in laboratory trials. Dis Aquat Organ 2001 Jan 26; 44(1): 17–27PubMedCrossRef

65.

Umelo-Njaka E, Nomellini JF, Bingle WH, et al. Expression and testing of Pseudomonas aeruginosa vaccine candidate proteins prepared with the Caulobacter crescentus S-layer protein expression system. Vaccine 2001 Jan 8; 19(11-12): 1406–15PubMedCrossRef

66.

Tremblay D, Lemay J, Gilbert M, et al. High-level heterologous expression and secretion in Streptomyces lividans of two major antigenic proteins from Mycobacterium tuberculosis. Can J Microbiol 2002 Jan; 48(1): 43–8PubMedCrossRef

67.

Pozidis C, Lammertyn E, Politou AS, et al. Protein secretion biotechnology using Streptomyces lividans: large-scale production of functional trimeric tumor necrosis factor alpha. Biotechnol Bioeng 2001 Mar 20; 72(6): 611–9PubMedCrossRef

68.

Tutino ML, Duilio A, Parrilli R, et al. A novel replication element from an Antarctic plasmid as a tool for the expression of proteins at low temperature. Extremophiles 2001 Aug; 5(4): 257–64PubMedCrossRef

69.

Gellissen G, Hollenberg CP. Application of yeasts in gene expression studies: a comparison of Saccharomyces cerevisiae, Hansenula polymorpha and Kluyveromyces lactis: a review. Gene 1997 Apr 29; 190(1): 87–97PubMedCrossRef

70.

Schaffrath R, Breunig KD. Genetics and molecular physiology of the yeast Kluyveromyces lactis. Fungal Genet Biol 2000 Aug; 30(3): 173–90PubMedCrossRef

71.

Cereghino GP, Cereghino JL, Ilgen C, et al. Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. Curr Opin Biotechnol 2002 Aug; 13(4): 329–32PubMedCrossRef

72.

Gellissen G, Melber K. Methylotrophic yeast Hansenula polymorpha as production organism for recombinant pharmaceuticals. Arzneimittel Forschung 1996 Sep; 46(9): 943–8PubMed

73.

Branduardi P. Molecular cloning and sequence analysis of the Zygosaccharomyces bailii HIS3 gene encoding the imidazole glycerolphosphate dehydratase. Yeast 2002 Sep 30; 19(13): 1165–70PubMedCrossRef

74.

Madzak C, Treton B, Blanchin-Roland S. Strong hybrid promoters and integrative expression/secretion vectors for quasi-constitutive expression of heterologous proteins in the yeast Yarrowia lipolytica. J Mol Microbiol Biotechnol 2000 Apr; 2(2): 207–16PubMed

75.

Nicaud JM, Madzak C, van den Broek P, et al. Protein expression and secretion in the yeast Yarrowia lipolytica. FEM Yeast Res 2002 Aug; 2(3): 371–9

76.

Garnick RL. Safety aspects in the quality control of recombinant products from mammalian cell culture. J Pharm Biomed Anal 1989; 7(2): 255–66PubMedCrossRef

77.

Hesse F, Wagner R. Developments and improvements in the manufacturing of human therapeutics with mammalian cell cultures. Trends Biotechnol 2000 Apr; 18(4): 173–80PubMedCrossRef

78.

Ikonomou L, Drugmand JC, Bastin G, et al. Microcarrier culture of lepidopteran cell lines: implications for growth and recombinant protein production. Biotechnol Prog 2002 Dec 6; 18(6): 1345–55PubMedCrossRef

79.

Marchai I, Jarvis DL, Cacan R, et al. Glycoproteins from insect cells: sialylated or not? Biol Chem 2001 Feb; 382(2): 151–9

80.

Ma JK, Hikmat BY, Wycoff K, et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med 1998 May; 4(5): 601–6PubMedCrossRef

81.

Zeitlin L, Olmsted SS, Moench TR, et al. A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nat Biotechnol 1998 Dec; 16(13): 1361–4PubMedCrossRef

82.

Borisjuk NV, Borisjuk LG, Logendra S, et al. Production of recombinant proteins in plant root exudates. Nat Biotechnol 1999 May; 17(5): 466–9PubMedCrossRef

83.

Gaume A, Komarnytsky S, Borisjuk N, et al. Rhizosecretion of recombinant proteins from plant hairy roots. Plant Cell Rep 2003 Aug; 21(12): 1188–93PubMedCrossRef

84.

Mayfield SP, Franklin SE, Lerner RA. Expression and assembly of a fully active antibody in algae. Proc Natl Acad Sci U S A 2003 Jan 21; 100(2): 438–42PubMedCrossRef

85.

Clark AJ. Gene expression in the mammary glands of transgenic animals. Biochem Soc Symp 1998; 63: 133–40PubMed

86.

Niemann H, Halter R, Carnwath JW, et al. Expression of human blood clotting factor VIII in the mammary gland of transgenic sheep. Transgenic Res 1999 Jun; 8(3): 237–47PubMedCrossRef

87.

Hiripi L, Makovics F, Halter R, et al. Expression of active human blood clotting factor VIII in mammary gland of transgenic rabbits. DNA Cell Biol 2003 Jan; 22(1): 41–5PubMedCrossRef

88.

Lui VC, Tam PK, Leung MY, et al. Mammary gland-specific secretion of biologically active immunosuppressive agent cytotoxic-T-lymphocyte antigen 4 human immunoglobulin fusion protein (CTLA4Ig) in milk by transgenesis. J Immunol Methods 2003 Jun 1; 277(1-2): 171–83PubMedCrossRef

89.

Keefer CL, Keyston R, Lazaris A, et al. Production of cloned goats after nuclear transfer using adult somatic cells. Biol Reprod 2002 Jan; 66(1): 199–203PubMedCrossRef

90.

Ryabova LA, Morozov IYu, Spirin AS. Continuous-flow cell-free translation, transcription-translation, and replication-translation systems. Methods Mol Biol 1998; 77: 179–93PubMed

91.

Martin GA, Kawaguchi R, Lam Y, et al. High-yield, in vitro protein expression using a continuous-exchange, coupled transcription/translation system. Biotechniques 2001 Oct; 31(4): 948–50, 952-3PubMed

92.

Fernholz E, Zaiss K, Besir H, et al. The expression of disulfide bonded proteins in cell-free protein expression. Spirin AS, editor. Cell-free translation systems. Berlin: Springer, 2002: 175–9CrossRef

93.

Kigawa T, Muto Y, Yokoyama S. Cell-free synthesis and amino acid-selective stable isotope labeling of proteins for NMR analysis. J Biomol NMR 1995 Sep; 6(2): 129–34PubMedCrossRef

94.

Shimizu Y, Inoue A, Tomari Y, et al. Cell-free translation reconstituted with purified components. Nat Biotechnol 2001 Aug; 19(8): 751–5PubMedCrossRef

95.

Uzawa T, Yamagishi A, Oshima T. Continuous cell-free protein synthesis directed by messenger DNA and catalyzed by extract of Thermus thermophilus HB27. Biosci Biotechnol Biochem 2003 Mar; 67(3): 639–42PubMedCrossRef

96.

Kigawa T, Yokoyama S. High-throughput cell-free protein expression system for structural genomics and proteomics studies. Tanpakushitsu Kakusan Koso 2002 Jun; 47(8 Suppl.): 1014–9PubMed

97.

Sawasaki T, Ogasawara T, Morishita R, et al. A cell-free protein synthesis system for high-throughput proteomics. Proc Natl Acad Sci U S A 2002 Nov 12; 99(23): 14652–7PubMedCrossRef

98.

Breitling R, Klingner S, Callewaert N, et al. Non-pathogenic trypanosomatid protozoa as a platform for protein research and production. Protein Expr Purif 2002 Jul; 25(2): 209–18PubMedCrossRef

Title: Expression Systems for the Production of Recombinant Pharmaceuticals
Author: Dr Régis Sodoyer
Publication date: 01-01-2004
Publisher: Springer International Publishing
Published in: BioDrugs / Issue 1/2004
Print ISSN: 1173-8804
Electronic ISSN: 1179-190X
DOI: https://doi.org/10.2165/00063030-200418010-00005

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Expression Systems for the Production of Recombinant Pharmaceuticals

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2004

Novel Strategies for the Prevention of Bypass Graft Failure

Cytokines as Therapeutic Targets for Osteoarthritis

Proinflammatory Cytokines in the Treatment of Bacterial and Fungal Infections

Intravenous Immunoglobulin Plus Interferon-α in Autoimmune Hepatitis C

A Multi-Model Approach to Nucleic Acid-Based Drug Development